Journal of magnetic resonance imaging : JMRI
-
J Magn Reson Imaging · Feb 2014
Randomized Controlled Trial Multicenter StudyGadobutrol in the central nervous system at three doses: results from a phase II, randomized, multicenter trial.
To investigate the efficacy and safety of three doses of gadobutrol and determine the minimum effective dose for contrast-enhanced MRI of the central nervous system (CNS). ⋯ The 0.1 mmol/kg dose of gadobutrol was effective and well tolerated for contrast-enhanced MRI of the CNS.